Archives
-
Ceftazidime Workflows for Gram-Negative Research
2026-08-25
Ceftazidime combines strong in vitro activity against aerobic Gram-negative organisms with a practical role in susceptibility, respiratory, and resistance-surveillance workflows. This guide connects reagent handling and broth microdilution with plasmid-localization and transmission data from carbapenem-resistant Enterobacter cloacae research.
-
Annexin V: Recombinant PS-Binding Protein
2026-08-24
Annexin V is a calcium-dependent phosphatidylserine binding protein for research on apoptosis and membrane changes. The K2064 reagent is an unlabeled human recombinant preparation supplied at 1 mg/mL in PBS and stored at -20°C.
-
CB-5083: Reframing p97 in Translational Oncology
2026-08-24
A mechanistic and strategic perspective on how CB-5083 can help translational researchers connect p97-dependent protein quality control with DNA repair, proteotoxic stress, and oncology model selection.
-
Pazopanib Hydrochloride Assay Workflows
2026-08-23
Build more informative cancer research assays with Pazopanib Hydrochloride by separating growth inhibition from true cell killing. This practical guide covers dose design, angiogenesis-relevant models, quantitative readouts, and troubleshooting for renal cell carcinoma and soft tissue sarcoma studies.
-
Carbapenemase Transmission in CREC Across Guangdong
2026-08-22
Chen et al. combined gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element profiling, and ERIC-PCR typing to examine carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. The study shows that plasmid-associated blaNDM-1 was prevalent and highly transferable, while strain clustering supports concurrent horizontal gene dissemination and clonal spread.
-
Carbapenemase Gene Transmission in CREC Hospitals
2026-08-22
Chen et al. integrate gene-localization analysis, antimicrobial susceptibility testing, conjugation assays, mobile-element screening, and ERIC-PCR across 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals. The study distinguishes gene presence from plasmid mobility and clonal relatedness, providing a practical framework for antimicrobial resistance research and hospital surveillance.
-
Rosiglitazone and the Next Era of Adipose Biology
2026-08-21
A translational perspective on how Rosiglitazone and Brl-49653 can be used to connect PPARγ-driven adipogenesis with beige-fat thermogenesis, insulin sensitivity, and the SEMA3E/β-catenin axis.
-
Cy5-Labeled mRNA for Delivery Assay Design
2026-08-20
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) supports a two-dimensional view of mRNA delivery: where the cargo goes and whether it is translated. This article explains how to interpret Cy5 and EGFP signals alongside nanoparticle morphology, formulation variables, and orthogonal controls.
-
ATS-9R: From Delivery Peptide to Adipose Mechanism
2026-08-20
ATS-9R enables targeted gene silencing in adipocytes and white adipose tissue through Prohibitin-mediated endocytosis. This article moves beyond delivery claims to explain how the FAM83A study can guide cargo selection, mitochondrial readouts, and interpretation of metabolic phenotypes.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-08-19
Hydroxychloroquine Sulfate (SKU B4874) supports aqueous workflows for examining autophagy pathway modulation and TLR7/9-associated immune responses in autoimmune disease research. It is not suitable for DMSO- or ethanol-based stocks or for protocols that require long-term storage of prepared solutions.
-
Toremifene in Breast Cancer: 20 Years of Evidence
2026-08-19
The review “Toremifene for Breast Cancer: A Review of 20 Years of Data” synthesizes clinical, pharmacologic, and safety evidence for toremifene as an endocrine treatment for hormone-sensitive breast cancer. Its central contribution is a nuanced comparison with tamoxifen and aromatase inhibitors, showing that toremifene is an effective option for selected postmenopausal patients without a confirmed overall safety advantage.
-
1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src assays
2026-08-18
PP 3 provides a practical negative-control framework for separating Src-dependent effects from compound-independent changes in vascular and cellular assays. This research use only chemical can strengthen Src kinase signaling pathway research when paired with matched PP 2 exposure, vehicle controls, and orthogonal pathway readouts.
-
Molidustat: Reframing HIF Stabilization for Translation
2026-08-18
Molidustat (BAY85-3934) offers a mechanistically grounded way to study endogenous erythropoietin stimulation in chronic kidney disease anemia. This thought-leadership analysis connects HIF-PH inhibition with Septin4–VHL control of HIF-1α stability, while distinguishing established renal anemia applications from early cardiovascular hypotheses.
-
Ceftazidime Workflows for Gram-Negative Resistance
2026-08-17
Ceftazidime enables controlled susceptibility, selection, and infection-modeling workflows centered on Pseudomonas aeruginosa and other Gram-negative organisms. This guide translates carbapenem-resistant Enterobacter cloacae surveillance into practical assay design, plasmid-transfer experiments, and troubleshooting decisions.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-08-17
Use α-Bungarotoxin to distinguish α7 nicotinic acetylcholine receptor signaling from nonspecific cholinergic effects in cell, tissue, and receptor assays. This workflow translates findings from placental necroptosis research into practical receptor-blockade experiments while emphasizing controls, optimization, and toxin-handling discipline.